Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24021727 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jungeun An und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Jeonbuk National University, Jeonju 54896, Republic of Korea. Hauptthemen laut MEDLINE: Neoplasms, Hematologic Diseases, Dioxygenases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation grants of Korea, Center for Genomic Integrity, Institute for Basic Science.
Abstract (Originalsprache)
The mammalian DNA methylation landscape is established and maintained by the combined activities of the two key epigenetic modifiers, DNA methyltransferases (DNMT) and Ten-eleven-translocation (TET) enzymes. Once DNMTs produce 5-methylcytosine (5mC), TET proteins fine-tune the DNA methylation status by consecutively oxidizing 5mC to 5-hydroxymethylcytosine (5hmC) and further oxidized derivatives. The 5mC and oxidized methylcytosines are essential for the maintenance of cellular identity and function during differentiation. Cytosine modifications with DNMT and TET enzymes exert pleiotropic effects on various aspects of hematopoiesis, including self-renewal of hematopoietic stem/progenitor cells (HSPCs), lineage determination, differentiation, and function. Under pathological conditions, these enzymes are frequently dysregulated, leading to loss of function. In particular, the loss of DNMT3A and TET2 function is conspicuous in diverse hematological disorders, including myeloid and lymphoid malignancies, and causally related to clonal hematopoiesis and malignant transformation. Here, we update recent advances in understanding how the maintenance of DNA methylation homeostasis by DNMT and TET proteins influences normal hematopoiesis and malignant transformation, highlighting the potential impact of DNMT3A and TET2 dysregulation on clonal dominance and evolution of pre-leukemic stem cells to full-blown malignancies. Clarification of the normal and pathological functions of DNA-modifying epigenetic regulators will be crucial to future innovations in epigenetic therapies for treating hematological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, Jeonbuk National University, Jeonju 54896, Republic of Korea.
- Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
- Center for Genomic Integrity, Institute for Basic Science, Ulsan 44919, Republic of Korea.
ORCID-Profile: Jungeun An
Förderung
- National Research Foundation grants of Korea
- Center for Genomic Integrity, Institute for Basic Science
Zitieren
APA
An, J., & Ko, M. (2023). Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021727
Vancouver
An J, Ko M. Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021727
BibTeX
@article{An2023,
author = {An, Jungeun and Ko, Myunggon},
title = {Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24021727}
}
EUVIMED